Natera, Inc. (NTRA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NTRA currently has 135M outstanding shares. with limited dilution risk as only 1.95M additional shares (1.4%) are authorized for issuance. The company has minimally diluted shareholders by 9.56% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Dec 05, 2025 |
S-3 filing: This prospectus relates to the potential resale from time to time of up to an aggregate of 1,952,565 shares of common stock of Natera, Inc. by the selling stockholders identified in this prospectus. |
130M | 2M |
| Dec 05, 2025 |
8-K filing: Natera, Inc. acquired Foresight Diagnostics Inc. and issued 1,127,982 shares of common stock as consideration, with a potential for an additional 824,583 shares to be issued in the future based on certain milestones and adjustments. |
130M | 0 |
| May 09, 2025 |
10-Q filing | 134.8M shares outstanding |
130M | 0 |
| Feb 28, 2025 |
10-K filing | 124.7M shares outstanding |
120M | 0 |
| Nov 12, 2024 |
10-Q filing | 123.8M shares outstanding |
120M | 0 |
| Aug 09, 2024 |
10-Q filing | 122.9M shares outstanding |
120M | 0 |
| May 10, 2024 |
10-Q filing | 120.8M shares outstanding |
120M | 0 |
| Feb 29, 2024 |
10-K filing | 115.0M shares outstanding |
110M | 0 |
| Nov 09, 2023 |
10-Q filing | 115.2M shares outstanding |
120M | 0 |
| Sep 07, 2023 |
8-K filing: Natera, Inc. has entered into an underwriting agreement to offer and sell 4,550,000 shares of common stock at a price of $55.00 per share, with an option for the underwriters to purchase up to 682,500 additional shares. ($506.2M proceeds) |
110M | 0 |
| Aug 04, 2023 |
10-Q filing | 113.7M shares outstanding |
110M | 0 |
| May 10, 2023 |
10-Q filing | 111.8M shares outstanding |
110M | 0 |
| Mar 01, 2023 |
10-K filing | 111.3M shares outstanding |
110M | 0 |
| Nov 16, 2022 |
8-K filing: Natera, Inc. announced an offering of 11,430,000 shares of common stock at a price of $35.00 per share, with an option for underwriters to purchase an additional 1,714,500 shares. ($400.05M proceeds) |
97M | 0 |
| Nov 09, 2022 |
10-Q filing | 97.1M shares outstanding |
97M | 0 |
| Aug 05, 2022 |
10-Q filing | 96.6M shares outstanding |
97M | 0 |
| May 06, 2022 |
10-Q filing | 95.6M shares outstanding |
96M | 0 |
| Feb 25, 2022 |
10-K filing | 90.6M shares outstanding |
91M | 0 |
| Nov 05, 2021 |
10-Q filing | 94.5M shares outstanding |
95M | 0 |
| Aug 06, 2021 |
10-Q filing | 88.5M shares outstanding |
88M | 0 |
| Jul 22, 2021 |
8-K filing: Natera, Inc. entered into an underwriting agreement to offer and sell 4,500,000 shares of common stock at a price of $113.00 per share, with an option for the underwriters to purchase an additional 675,000 shares. The offering is expected to close on July 26, 2021. ($508.5M proceeds) |
87M | 0 |
| May 07, 2021 |
10-Q filing | 87.4M shares outstanding |
87M | 0 |
| Feb 26, 2021 |
10-K filing | 86.2M shares outstanding |
86M | 0 |
| Nov 06, 2020 |
10-Q filing | 85.3M shares outstanding |
85M | 0 |
| Sep 11, 2020 |
8-K filing: Natera, Inc. announced the offering of 4,166,666 shares of common stock at a price of $60.00 per share, with the underwriters having an option to purchase up to 624,999 additional shares, with expected net proceeds of approximately $235.3 million, or approximately $270.6 million if the Underwriters exercise in full their option. ($250.0M proceeds) |
80M | 0 |
| Aug 07, 2020 |
10-Q filing | 79.7M shares outstanding |
80M | 0 |
| May 08, 2020 |
10-Q filing | 78.7M shares outstanding |
79M | 0 |
| Apr 16, 2020 |
8-K filing: Natera, Inc. sold $287.5 million aggregate principal amount of 2.25% Convertible Senior Notes due 2027 in a private placement, with a maximum of 9,634,700 shares of common stock potentially issuable upon conversion. |
N/A | 0 |